2023ChatGPT醫(yī)療行業(yè)應(yīng)用白皮書

ChatGPT

Application inHealthcare

Report2023年9月101

02

03

0

4 C

h

a

t

GPT24數(shù)據(jù)來源：OpenAI官網(wǎng)（

/

）ChatGPTOpenAILLMGPTChatGPT/2020.6.11GPT-3?

GPT-3?2022.11.30ChatGPT/GPT-3.5?

ChatGPT GPT-3.5?2023.3.14GPT-4?/??ChatGPTChatGPT5數(shù)據(jù)來源：行業(yè)公開信息整理。????2023ChatGPT6數(shù)據(jù)來源：案例采用ChatGPT（GPT-4模型）對話。7數(shù)據(jù)來源：案例采用ChatGPT（GPT-4模型）對話。8數(shù)據(jù)來源：案例采用ChatGPT（GPT-4模型）對話。9數(shù)據(jù)來源：行業(yè)公開信息整理。ChatGPTPaLMAIPubMedGPT

Med-AIAIAI20222022OpenAIChatGPT10PubMedGPT數(shù)據(jù)來源：

/stanford-crfm/BioMedLM???????PubMedGPT BioMedLMStanford MosaicML?????????11數(shù)據(jù)來源：谷歌，https://sites.research.google/med-palm/50.36067.2

85.4 9080706050403020100PubMedGPTMed-PaLMMed-PaLM2AIMed-PaLMMed-PaLM267.285.4PubMedGPTMed-PaLMPubMedGPTvs

Med-PaLM12數(shù)據(jù)來源：谷歌，https://sites.research.google/med-palm/13Dragon數(shù)據(jù)來源：/michiyasunaga/dragon???????DRAGONDRAGON(DeepBidirectionalLanguage-KnowledgeGraph

Pretraining)Stanford

University-?????????JohnsNvidiaHippocraticMedicareHopkins Stanford GoogleAIGeneral

CatalystHippocratic”14數(shù)據(jù)來源：官網(wǎng)（）70.9%76.2%65.3%80.3%48.5%71.4%91.1%88.6%71.0%92.3%72.7%83.7%100%90%80%70%60%50%40%30%20%10%0%GPT-4Hippocratic

AI?????HippocraticGPT-415數(shù)據(jù)來源：官網(wǎng)（）16數(shù)據(jù)來源：行業(yè)公開信息整理。???QALLMQAQA17數(shù)據(jù)來源：/jind11/MedQA??Question:A57-year-oldmanpresentstohisprimarycarephysicianwitha2-monthhistoryofrightupperandlowerextremityweakness.Henoticedtheweaknesswhenhestartedfallingfarmorefrequentlywhilerunningerrands.Sincethen,hehashadincreasingdifficultywithwalkingandliftingobjects.Hispastmedicalhistoryissignificantonlyforwell-controlledhypertension,buthesaysthatsomemembersofhisfamilyhave

hadmusculoskeletalproblems.HisrightupperextremityshowsforearmatrophyanddepressedreflexeswhilehisrightlowerextremityishypertonicwithapositiveBabinskisign.Whichofthefollowingismostlikelyassociatedwiththecauseofthispatients

symptoms?Options:A:

HLA-B8

haplotype,

B:

HLA-DR2

haplotype,

C:

Mutation

inSOD1,D:MutationinSMN1,E:Viral

infection（答案為A）????????MedQA-USMLE?18數(shù)據(jù)來源：https://huggingface.co/datasets/pubmed_qa????????????Question:Dopreoperativestatinsreduceatrialfibrillationafter

coronaryarterybypass

grafting?Context:(Objective)Recentstudieshavedemonstratedthatstatins

havepleiotropiceffects,includinganti-inflammatoryeffectsandatrialfibrillation(AF)preventiveeffects

[...](Methods)221patientsunderwentCABGinourhospitalfrom2004to2007.14patientswithpreoperativeAFand4patientswithconcomitantvalvesurgery

[...](Results)TheoverallincidenceofpostoperativeAFwas

26%.PostoperativeAFwassignificantlylowerintheStatin

groupcomparedwiththeNon-statingroup(16%versus33%,

p=0.005).[...]Long

Answer:(Conclusion)

Our

study

indicated

that

preoperative

statin

therapyseemstoreduceAFdevelopmentafter

CABG.Answer:

yesPubMedQAQA19?Question：Chronicurethralobstructionduetobenignprismatichyperplasiacanleadtothefollowingchangeinkidney

parenchyma?Options:HyperplasiaHyperophyAtrophyDysplasiaCorrectAnswer:c)

AtrophyExplanation:Chronicurethralobstructionbecauseofurinarycalculi,

prostatichyperophy,tumors,normal

pregnancy[…]Subject:

AnatomyTopic:Urinary

tract??????????MedMCQA Subject數(shù)據(jù)來源：https://huggingface.co/datasets/medmcqaTopic20數(shù)據(jù)來源：/dataset/frenchmedmcqa?????????Question：Cocherla(les)proposition(s)exacte(s):Le

métronidazoleOptions:Estundérivédu

pyrazolePeutinduireuneffet

antabusePeutêtreadministréparvoieparentérale

intraveineusePeutêtreutilisédanscertainesparasitoses

àprotozoairesEstinefficacedanslesinfectionsàgermes

anaérobiesCorrect

Answer:Peutinduireuneffet

antabusePeutêtreadministréparvoieparentérale

intraveineusePeutêtreutilisédanscertainesparasitoses

àprotozoairesFrenchMedMCQAAI?22注：*

表示潛在的應(yīng)用場景（暫無落地案例覆蓋）ChatGPTChatGPT23數(shù)據(jù)來源：

kahun公司官網(wǎng)（

）24注：案例展示為測試版軟件演示，kahun公司尚未披露產(chǎn)品應(yīng)用后的實際數(shù)據(jù)。?ChatGPT?????25數(shù)據(jù)來源：公司官網(wǎng)（

）26數(shù)據(jù)來源：官網(wǎng)（）27數(shù)據(jù)來源：截圖來自軟件試用，指標(biāo)數(shù)據(jù)來自官網(wǎng)（）/2350%Nabla

Copilot28數(shù)據(jù)來源：官網(wǎng)（

）29數(shù)據(jù)來源：官網(wǎng)（

），

DocsGPT網(wǎng)站（

www.DocsGPT.com）30數(shù)據(jù)來源：DocsGPT網(wǎng)站（

www.DocsGPT.com）GPTDocsGPT31數(shù)據(jù)來源：官網(wǎng)（）33??34數(shù)據(jù)來源：官網(wǎng)（）、ChatGPT

Plugin

Store35數(shù)據(jù)來源：官網(wǎng)（）、ChatGPT

Plugin

Store36數(shù)據(jù)來源：

Clinical

Trial

Radar（ChatGPT插件）37數(shù)據(jù)來源：

Clinical

Trial

Radar（ChatGPT插件）COVID-1938數(shù)據(jù)來源：

Clinical

Trial

Radar（ChatGPT插件）39數(shù)據(jù)來源：官網(wǎng)（www.

www.ferma.ai）生命科學(xué)網(wǎng)站、新聞，官方發(fā)布FDA

Labeling（藥品和醫(yī)療器械標(biāo)簽上的信息和要求的規(guī)定）美國證券交易委員會報告（SEC

Calls）財報電話會議（Earning

Calls）PubMed醫(yī)學(xué)文獻(xiàn)數(shù)據(jù)庫Clinical

Trial數(shù)據(jù)庫1 行業(yè)新聞2 藥審監(jiān)管3 財經(jīng)信息4 醫(yī)學(xué)數(shù)據(jù)信息源回答質(zhì)